BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25781674)

  • 21. The Mechanisms of Type 2 Diabetes-Related White Matter Intensities: A Review.
    Sun J; Xu B; Zhang X; He Z; Liu Z; Liu R; Nan G
    Front Public Health; 2020; 8():498056. PubMed ID: 33282807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-Nucleotide Polymorphisms of Tight Junction Component Claudin-1 Associated with Leukoaraiosis.
    Yadav BK; Shin BS
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1662-70. PubMed ID: 25956626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebral white matter hyperintensities on MRI: Current concepts and therapeutic implications.
    Ovbiagele B; Saver JL
    Cerebrovasc Dis; 2006; 22(2-3):83-90. PubMed ID: 16685119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship of leukoaraiosis and the clinical severity of vascular Parkinsonism.
    Chen YF; Tseng YL; Lan MY; Lai SL; Su CS; Liu JS; Chang YY
    J Neurol Sci; 2014 Nov; 346(1-2):255-9. PubMed ID: 25240444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Age-related white matter lesions (leukoaraiosis): an update].
    Miki Y; Sakamoto S
    Brain Nerve; 2013 Jul; 65(7):789-99. PubMed ID: 23832982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leukoaraiosis: an independent risk factor for stroke?
    Inzitari D
    Stroke; 2003 Aug; 34(8):2067-71. PubMed ID: 12829859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Grading and interpretation of white matter hyperintensities using statistical maps.
    Ryu WS; Woo SH; Schellingerhout D; Chung MK; Kim CK; Jang MU; Park KJ; Hong KS; Jeong SW; Na JY; Cho KH; Kim JT; Kim BJ; Han MK; Lee J; Cha JK; Kim DH; Lee SJ; Ko Y; Cho YJ; Lee BC; Yu KH; Oh MS; Park JM; Kang K; Lee KB; Park TH; Lee J; Choi HK; Lee K; Bae HJ; Kim DE
    Stroke; 2014 Dec; 45(12):3567-75. PubMed ID: 25388424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and risk factors of leukoaraiosis from 4683 hospitalized patients: A cross-sectional study.
    Lin Q; Huang WQ; Ma QL; Lu CX; Tong SJ; Ye JH; Lin HN; Gu L; Yi KH; Cai LL; Tzeng CM
    Medicine (Baltimore); 2017 Sep; 96(39):e7682. PubMed ID: 28953609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurochemical correlates of cognitive dysfunction in patients with leukoaraiosis: a proton magnetic resonance spectroscopy study.
    Wang S; Yuan J; Guo X; Peng P; Gu H; Niu S; Fregni F; Chen AC; Hu W
    Neurol Res; 2012 Dec; 34(10):989-97. PubMed ID: 23146302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of cerebral white matter changes on functionality in older adults: An overview of the LADIS Study results and future directions.
    Pantoni L; Fierini F; Poggesi A;
    Geriatr Gerontol Int; 2015 Dec; 15 Suppl 1():10-6. PubMed ID: 26671152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropsychological test findings in subjects with leukoaraiosis.
    Rao SM; Mittenberg W; Bernardin L; Haughton V; Leo GJ
    Arch Neurol; 1989 Jan; 46(1):40-4. PubMed ID: 2910260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebral white matter hyperintensities (WMH): an analysis of cerebrovascular risk factors in Lebanon.
    Gebeily S; Fares Y; Kordahi M; Khodeir P; Labaki G; Fazekas F
    Int J Neurosci; 2014 Nov; 124(11):799-805. PubMed ID: 24433122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secondary demyelination disorders and destruction of white matter.
    Ryan M; Ibrahim M; Parmar HA
    Radiol Clin North Am; 2014 Mar; 52(2):337-54. PubMed ID: 24582343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated analysis of microRNA and mRNA expression profiling identifies
    Huang WQ; Lin Q; Chen S; Sun L; Chen Q; Yi K; Li Z; Ma Q; Tzeng CM
    Aging (Albany NY); 2021 Feb; 13(3):4674-4695. PubMed ID: 33561007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. White matter hyperintensities and geriatric syndrome: An important role of arterial stiffness.
    Saji N; Ogama N; Toba K; Sakurai T
    Geriatr Gerontol Int; 2015 Dec; 15 Suppl 1():17-25. PubMed ID: 26671153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Linking MRI hyperintensities with patterns of neuropsychological impairment: evidence for a threshold effect.
    Libon DJ; Price CC; Giovannetti T; Swenson R; Bettcher BM; Heilman KM; Pennisi A
    Stroke; 2008 Mar; 39(3):806-13. PubMed ID: 18258842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study.
    Longstreth WT; Arnold AM; Beauchamp NJ; Manolio TA; Lefkowitz D; Jungreis C; Hirsch CH; O'Leary DH; Furberg CD
    Stroke; 2005 Jan; 36(1):56-61. PubMed ID: 15569873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetes mellitus and white matter hyperintensity.
    Tamura Y; Araki A
    Geriatr Gerontol Int; 2015 Dec; 15 Suppl 1():34-42. PubMed ID: 26671155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leukoaraiosis and ambulatory blood pressure load in a healthy elderly cohort study: the PROOF study.
    Avet J; Pichot V; Barthélémy JC; Laurent B; Garcin A; Roche F; Celle S
    Int J Cardiol; 2014 Mar; 172(1):59-63. PubMed ID: 24495649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular dementia in leukoaraiosis may be a consequence of capillary loss not only in the lesions, but in normal-appearing white matter and cortex as well.
    Brown WR; Moody DM; Thore CR; Challa VR; Anstrom JA
    J Neurol Sci; 2007 Jun; 257(1-2):62-6. PubMed ID: 17320909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.